All Documents

Events

Events & Presentations

Investor Video

View Video

Press Releases

Oct 10, 2021
BeiGene Announces BRUKINSA® (Zanubrutinib) Approved for Treatment of Patients with Mantle Cell Lymphoma    read more...
Oct 07, 2021
BeiGene Announces First Regulatory Approval in Australia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Waldenström’s Macroglobulinemia    read more...
Sep 20, 2021
BeiGene Announces Inclusion in FTSE Russell Indices    read more...
Press Releases

Thank you for your interest in Beigene, Ltd ! You will receive an email shortly. Please confirm your email address by clicking the link inside.

Back to the form